StockData
Geron Corp logo

Geron Corp (GERN) stock

GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$0.99−0.01 (-0.91%)

Close on Nov 18, 2026Market cap $636.63MP/E –Yield –

Geron price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Geron's price to sales ratio was 61.2× on Jan 31, 2025, against 403.0× a year earlier. Over the last 5 years it ranged from 8.1× to 499.5×, with a median of 255.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jan 31, 202561.2×−14.3
2024Dec 31, 202475.5×−378.8
2022Jul 29, 2022454.3×−45.2
2020Feb 28, 2020499.5×+116.3
2019Dec 31, 2019383.3×+190.9
2018Dec 31, 2018192.4×−103.6
2017Dec 29, 2017296.0×+243.3
2016Dec 30, 201652.7×+31.5
2015Dec 31, 201521.2×−375.7
2014Dec 31, 2014396.8×+49.7
2013Dec 31, 2013347.1×+268.6
2012Dec 31, 201278.5×−35.2
2011Jul 29, 2011113.8×–

More Geron figures

See a number that looks wrong?